CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Net Cash Provided by (Used in) Investing Activities, Continuing Operations
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) reported Net Cash Provided by (Used in) Investing Activities, Continuing Operations of -$851.04 million for the 6-month period ending 2018-06-30, per its 10-Q filed 2018-08-08.
Discontinued › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations · last filed 2018-08-08
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2018-06-30 was -$826.37M.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2018-03-31 was -$24.66M, a 146.54% decline year-over-year.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2017-12-30 was -$32.83M.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2017-09-30 was -$53.78M.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. net cash provided by (used in) investing activities, continuing operations for fiscal 2017 was -$72.59M.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. net cash provided by (used in) investing activities, continuing operations for fiscal 2016 was -$692.67M.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. net cash provided by (used in) investing activities, continuing operations for fiscal 2015 was -$327.62M.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. net cash provided by (used in) investing activities, continuing operations for fiscal 2014 was -$297.99M.
| Period end | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 3 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 6 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 6 month as first filed | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 9 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 9 month as first filed | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 12 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2018-06-30 | -$826.37M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-08 | -$851.04M 10-Q · filed 2018-08-08 | -$883.86M derived: sum of 3 quarters · filed 2018-08-08 | -$937.65M derived: sum of 4 quarters · filed 2018-08-08 | |||
| 2018-03-31 | -$24.66M 10-Q · filed 2018-05-10 | -$57.49M derived: sum of 2 quarters · filed 2018-05-10 | -$111.28M derived: sum of 3 quarters · filed 2018-05-10 | -$150.25M derived: sum of 4 quarters · filed 2018-08-08 | |||
| 2017-12-30 | -$32.83M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-13 | -$86.61M derived: sum of 2 quarters · filed 2018-02-13 | -$125.58M derived: sum of 3 quarters · filed 2018-08-08 | -$72.59M 10-K · filed 2018-02-13 | |||
| 2017-09-30 | -$53.78M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | -$92.75M derived: sum of 2 quarters · filed 2018-08-08 | -$39.76M 10-Q · filed 2017-11-09 | -$114.76M derived: sum of 4 quarters · filed 2018-08-08 | |||
| 2017-07-01 | -$38.97M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-08 | $14.03M 10-Q · filed 2018-08-08 | -$60.98M derived: sum of 3 quarters · filed 2018-08-08 | -$73.87M derived: sum of 4 quarters · filed 2018-08-08 | |||
| 2017-04-01 | $53.00M 10-Q · filed 2018-05-10 | -$22.01M derived: sum of 2 quarters · filed 2018-05-10 | -$34.90M derived: sum of 3 quarters · filed 2018-05-10 | -$633.23M derived: sum of 4 quarters · filed 2018-05-10 | |||
| 2016-12-31 | -$75.00M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-13 | -$87.90M derived: sum of 2 quarters · filed 2018-02-13 | -$686.23M derived: sum of 3 quarters · filed 2018-02-13 | -$692.67M 10-K · filed 2018-02-13 | -$686.37M 10-K · filed 2017-02-14 | ||
| 2016-09-24 | -$12.89M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | -$611.23M derived: sum of 2 quarters · filed 2017-11-09 | -$617.67M 10-Q · filed 2017-11-09 | -$615.43M 10-Q · filed 2016-11-02 | -$696.31M derived: sum of 4 quarters · filed 2018-02-13 | ||
| 2016-06-25 | -$598.33M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | -$604.78M 10-Q · filed 2017-08-09 | -$683.41M derived: sum of 3 quarters · filed 2018-02-13 | -$895.90M derived: sum of 4 quarters · filed 2018-02-13 | |||
| 2016-03-26 | -$6.44M 10-Q · filed 2017-05-10 | -$85.08M derived: sum of 2 quarters · filed 2018-02-13 | -$297.57M derived: sum of 3 quarters · filed 2018-02-13 | -$321.76M derived: sum of 4 quarters · filed 2018-02-13 | |||
| 2015-12-26 | -$78.64M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-13 | -$291.13M derived: sum of 2 quarters · filed 2018-02-13 | -$315.32M derived: sum of 3 quarters · filed 2018-02-13 | -$327.62M 10-K · filed 2018-02-13 | -$320.29M 10-K · filed 2016-02-12 | ||
| 2015-09-26 | -$212.49M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-02 | -$236.69M derived: sum of 2 quarters · filed 2016-11-02 | -$248.98M 10-Q · filed 2016-11-02 | -$329.78M derived: sum of 4 quarters · filed 2017-02-14 | |||
| 2015-06-27 | -$24.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-03 | -$36.49M 10-Q · filed 2016-08-03 | -$117.29M derived: sum of 3 quarters · filed 2017-02-14 | -$131.98M derived: sum of 4 quarters · filed 2017-02-14 | |||
| 2015-03-28 | -$12.29M 10-Q · filed 2016-05-04 | -$93.09M derived: sum of 2 quarters · filed 2017-02-14 | -$107.78M derived: sum of 3 quarters · filed 2017-02-14 | -$303.77M derived: sum of 4 quarters · filed 2017-02-14 | |||
| 2014-12-27 | -$80.80M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-14 | -$95.49M derived: sum of 2 quarters · filed 2017-02-14 | -$291.48M derived: sum of 3 quarters · filed 2017-02-14 | -$297.99M 10-K · filed 2017-02-14 | |||
| 2014-09-27 | -$14.69M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-04 | -$210.68M derived: sum of 2 quarters · filed 2015-11-04 | -$217.19M 10-Q · filed 2015-11-04 | -$236.90M derived: sum of 4 quarters · filed 2016-02-12 | |||
| 2014-06-28 | -$195.99M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-07-30 | -$202.50M 10-Q · filed 2015-07-30 | -$222.21M derived: sum of 3 quarters · filed 2016-02-12 | -$236.56M derived: sum of 4 quarters · filed 2016-02-12 | |||
| 2014-03-29 | -$6.51M 10-Q · filed 2015-04-30 | -$26.23M derived: sum of 2 quarters · filed 2016-02-12 | -$40.57M derived: sum of 3 quarters · filed 2016-02-12 | -$51.78M derived: sum of 4 quarters · filed 2016-02-12 | |||
| 2013-12-28 | -$19.71M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-12 | -$34.06M derived: sum of 2 quarters · filed 2016-02-12 | -$45.27M derived: sum of 3 quarters · filed 2016-02-12 | -$74.05M 10-K · filed 2016-02-12 | |||
| 2013-09-28 | -$14.35M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-30 | -$25.55M derived: sum of 2 quarters · filed 2014-10-30 | -$54.33M 10-Q · filed 2014-10-30 | -$74.11M derived: sum of 4 quarters · filed 2015-02-17 | |||
| 2013-06-29 | -$11.21M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07 | -$39.99M 10-Q · filed 2014-08-07 | -$59.76M derived: sum of 3 quarters · filed 2015-02-17 | -$86.40M derived: sum of 4 quarters · filed 2015-02-17 | |||
| 2013-03-30 | -$28.78M 10-Q · filed 2014-04-30 | -$48.56M derived: sum of 2 quarters · filed 2015-02-17 | -$75.19M derived: sum of 3 quarters · filed 2015-02-17 | -$80.49M derived: sum of 4 quarters · filed 2015-02-17 | |||
| 2012-12-29 | -$19.77M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-17 | -$46.41M derived: sum of 2 quarters · filed 2015-02-17 | -$51.71M derived: sum of 3 quarters · filed 2015-02-17 | -$54.99M 10-K · filed 2015-02-17 | |||
| 2012-09-29 | -$26.64M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-30 | -$31.94M derived: sum of 2 quarters · filed 2013-10-30 | -$35.22M 10-Q · filed 2013-10-30 | -$59.81M derived: sum of 4 quarters · filed 2014-02-25 | |||
| 2012-06-30 | -$5.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-07-31 | -$8.58M 10-Q · filed 2013-07-31 | -$33.17M derived: sum of 3 quarters · filed 2014-02-25 | -$37.34M derived: sum of 4 quarters · filed 2014-02-25 | |||
| 2012-03-31 | -$3.28M 10-Q · filed 2013-05-08 | -$27.87M derived: sum of 2 quarters · filed 2014-02-25 | -$32.04M derived: sum of 3 quarters · filed 2014-02-25 | -$27.39M derived: sum of 4 quarters · filed 2014-02-25 | |||
| 2011-12-31 | -$24.60M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-25 | -$28.77M derived: sum of 2 quarters · filed 2014-02-25 | -$24.11M derived: sum of 3 quarters · filed 2014-02-25 | -$36.65M 10-K · filed 2014-02-25 | |||
| 2011-09-24 | -$4.17M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-01 | $487.00K derived: sum of 2 quarters · filed 2012-11-01 | -$12.05M 10-Q · filed 2012-11-01 | -$23.68M derived: sum of 4 quarters · filed 2013-02-27 | |||
| 2011-06-25 | $4.66M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-07 | -$7.88M 10-Q · filed 2012-08-07 | -$19.51M derived: sum of 3 quarters · filed 2013-02-27 | -$25.62M derived: sum of 4 quarters · filed 2013-02-27 | |||
| 2011-03-26 | -$12.54M 10-Q · filed 2012-05-04 | -$24.16M derived: sum of 2 quarters · filed 2013-02-27 | -$30.28M derived: sum of 3 quarters · filed 2013-02-27 | -$43.80M derived: sum of 4 quarters · filed 2013-02-27 | |||
| 2010-12-25 | -$11.63M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-27 | -$17.74M derived: sum of 2 quarters · filed 2013-02-27 | -$31.26M derived: sum of 3 quarters · filed 2013-02-27 | $2.95M 10-K · filed 2013-02-27 | |||
| 2010-09-25 | -$6.11M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-02 | -$19.63M derived: sum of 2 quarters · filed 2011-11-02 | $14.58M 10-Q · filed 2011-11-02 | $17.38M 10-Q · filed 2010-11-04 | -$47.35M derived: sum of 4 quarters · filed 2012-02-27 | ||
| 2010-06-26 | -$13.52M derived: 10-Q 6 month − 10-Q 3 month · filed 2011-08-03 | $20.69M 10-Q · filed 2011-08-03 | $23.49M 10-Q · filed 2010-08-03 | -$41.23M derived: sum of 3 quarters · filed 2012-02-27 | -$39.36M derived: sum of 4 quarters · filed 2012-02-27 | ||
| 2010-03-27 | $34.22M 10-Q · filed 2011-05-04 | -$27.71M derived: sum of 2 quarters · filed 2012-02-27 | -$25.84M derived: sum of 3 quarters · filed 2012-02-27 | ||||
| 2009-12-26 | -$61.93M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-27 | -$60.05M derived: sum of 2 quarters · filed 2012-02-27 | -$209.08M 10-K · filed 2012-02-27 | ||||
| 2009-09-26 | $1.87M derived: 10-Q 9 month − 10-Q 6 month · filed 2010-11-04 | -$147.16M 10-Q · filed 2010-11-04 | |||||
| 2009-06-27 | -$149.03M 10-Q · filed 2010-08-03 | ||||||
| 2008-12-27 | -$228.74M 10-K · filed 2011-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |